MTMara P. H. van Trijp

Mara P. H. van Trijp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mara P. H. van Trijp has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Colon-delivered multivitamin supplementation enhances working memory-related fMRI responses in older adults: a randomized, placebo-controlled trial

    by Lianne B. Remie, Mark R. van Loenen, Mechteld M. Grootte Bromhaar, Noortje M.P. Overwater, Janne van Overbeek, Andrea Anesi, Urska Vrhovsek, Ateequr Rehman, Robert E. Steinert, Jurriaan J. Mes, et al.

    Background: Vitamins are important modulators of intestinal health and may affect the gut-brain axis through microbial metabolites such as short-chain fatty acids (SCFAs). However, the neurocognitive effects of colon-delivered vitamins in older adults remain unexplored − a critical gap given the gut-brain axis9s emerging role in cognitive aging. Objective: We investigated the effect of a colon-delivered multivitamin (CDMV) supplement on intestinal health and neurocognitive outcomes in older adults at risk of cognitive decline. Methods: Within the double-blind randomized placebo-controlled trial COMBI (ClinicalTrials.govID: NCT05675007), we included 75 older adults (60-75 years) at risk of cognitive decline based on lifestyle-related factors. Participants consumed a colon-delivered capsule with vitamins B2, B3, B6, B9, C and D3, or a placebo, daily for six weeks. Pre- and post-intervention, we employed neuroimaging, feces- and blood collection. Primary outcomes were fecal SCFA concentrations, working memory (WM)-related fMRI responses, and WM performance measured with the n-back task. Results: After adjusting for baseline values, we found no significant between-group differences in total fecal SCFA levels (p = 0.30) and WM performance (p = 0.50). Post-intervention WM-related fMRI responses in the hippocampus (p = 0.01; ηp2 = 0.09) and dorsolateral prefrontal cortex (dlPFC) (p = 0.06; ηp2 = 0.04), driven by the right dlPFC (p = 0.02), were higher in the CDMV group compared to placebo. Independent of intervention group, post-pre increases in fecal SCFA levels were significantly correlated to increases in dlPFC fMRI responses (ρ = 0.31; p = 0.02) and WM performance (ρ = 0.43; p = 0.001). Conclusions: Our findings suggest that CDMV supplementation increases WM-related responses of the dlPFC and hippocampus in older adults, but this effect was not accompanied by changes in fecal SCFA levels or WM performance. The positive correlation of within-subject changes in fecal SCFAs with changes in WM dlPFC responses and performance across intervention groups provides human evidence for gut-brain communication in cognitive aging beyond cross-sectional associations.

  • Open Access

    MIND-NL diet adherence moderates the relation of low-grade systemic inflammation with neuroinflammation and cognitive functioning: an exploratory cross-sectional study in older adults

    by Lianne B. Remie, Mark R. van Loenen, Mara P.H. van Trijp, Ilke G.S. de Lange, Yannick Vermeiren, Jurriaan J. Mes, Nicolaas A. Puts, Joukje M. Oosterman, Esther Aarts

    Background: Observational studies have linked high adherence to the “Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay” (MIND) diet to improved cognitive functions in older adults. The underlying peripheral and central mechanisms of this association remain poorly understood, although multiple nutrients in the MIND diet are known for their anti-inflammatory effects. Therefore, we explored the cross-sectional relation between MIND diet adherence (Dutch version), systemic inflammation, neuroinflammation, and cognitive functioning in older adults. In addition, we examined the role of intestinal barrier permeability in MIND diet associations with (neuro)inflammation. Methods: We included 88 older adults (60-75 year) at risk of cognitive decline. MIND-NL diet adherence was assessed using a food frequency questionnaire. Systemic inflammation (C-reactive protein levels, white blood cell-counts and neutrophil-to-lymphocyte ratio) and intestinal barrier permeability (lipopolysaccharide-binding protein, zonulin, and lipopolysaccharide) markers were measured in blood. Neuroinflammation-associated metabolites (myo-inositol, choline and creatine) were measured in the dorsolateral prefrontal cortex with proton magnetic resonance spectroscopy ( 1 H-MRS). Cognitive functioning was assessed with a neuropsychological test battery. Results: Linear models showed that both MIND diet adherence and systemic inflammation did not predict neuroinflammation or cognition independently. However, MIND diet adherence significantly moderated the relation between systemic inflammation and neuroinflammation (β=-0.11, p =0.04) as well as between systemic inflammation and cognition (β=0.044, p =0.02). Specifically, in individuals with lower MIND diet adherence (identified as scores ≤7), systemic inflammation was positively related to neuroinflammation, and negatively to cognition. Similarly, MIND diet adherence significantly moderated the relation between intestinal barrier permeability and neuroinflammation (β=-0.17, p =0.05). Finally, within participants with lower MIND adherence (median split at ≤8.75), systemic inflammation mediated the relation between the intestinal barrier permeability and neuroinflammation (β=0.427 [0.072; 0.891], p =0.04). Conclusion: Our findings suggest that higher MIND diet adherence might protect against the detrimental effect of systemic inflammation on neuroinflammation and cognitive functioning. Moreover, we demonstrated that greater adherence to the MIND diet may specifically protect against the systemic inflammation-mediated relationship between intestinal barrier permeability and neuroinflammation. These findings should be confirmed in randomised controlled trials.

  • Open Access

    The effects of a multidomain lifestyle intervention on brain functioning and its relation with immunometabolic markers and intestinal health in older adults at-risk of cognitive decline: study design and baseline characteristics of the HELI randomized controlled trial. (Preprint)

    by Mark R. van Loenen, Lianne B. Remie, Mara P.H. van Trijp, Michelle G. Jansen, José P. Marques, Jurgen A.H.R. Claassen, Ondine van de Rest, Yannick Vermeiren, Nynke Smidt, Sietske A.M. Sikkes, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Studies of multidomain lifestyle interventions show mixed results on preventing or delaying cognitive decline in ageing. A better understanding of the mechanisms underlying these interventions could help explain these mixed findings. Objective: The HELI study aims to investigate the brain and peripheral mechanisms of a multidomain lifestyle intervention in older adults at risk of cognitive decline. Methods: The HELI study is a 6-month multicentre, randomized, controlled multidomain lifestyle intervention trial powered to include 104 Dutch older adults at risk of cognitive decline. Individuals were deemed at risk when scoring ≥2 points on a lifestyle-modifiable risk factor scale (e.g. overweight, physical inactivity, hypertension, hypercholesterolemia). The multidomain lifestyle intervention consisted of five domains (diet, physical activity, stress management/mindfulness, cognitive training, and sleep) and participants were randomized in one of two intervention groups: (1) a high-intensity coaching group consisting of weekly supervised online and on-site group meetings, exercises and learning materials from lifestyle-specific course modules, and (2) a low-intensity coaching group consisting of general lifestyle-related health information sent through e-mail every two weeks. The primary study outcomes are changes between baseline and 6-month follow-up in (1) brain activation in dorsolateral prefrontal cortex (dlPFC) and hippocampus and task accuracy during an fMRI working memory task (2) ASL-quantified cerebral blood flow in dlPFC and hippocampus, (3) systemic inflammation from blood plasma (IL-6, TNF-α, hs-CRP) and (4) microbiota profile from faeces (gut microbiome diversity (Shannon and phylogenetic diversity) and richness (Chao1)). In addition, we will investigate intervention-induced gut-immune-brain links by assessing the relation between the effects found in the aforementioned primary brain and gut outcome measures. Secondary study outcomes include (1) structural and neurochemical MRI, (2) anthropometric measurements, (3) neuropsychological test battery scores, (4) lifestyle-domain related measures from questionnaire scores and a smartwatch, and an array of peripheral measures from (5) faecal analysis, (6) blood analysis, and (7) breath analysis. Results: Between April 2022 and October 2023 we have successfully included n = 102 older Dutch adults (mean age: 66.6 (SD: 4.3) years; 65.7% female) with ≥2 lifestyle-modifiable risk factors of cognitive ageing (median risk: 3 (IQR: 2, 3)). The most common self-reported lifestyle-modifiable risk factors of cognitive ageing at baseline were overweight or obesity (74.5%), followed by hypertension (56.9%), hypercholesterolemia (55.9%), and physical inactivity (55.9%). Conclusions: The HELI study aims to enhance our understanding of working mechanisms of multidomain lifestyle interventions through its comprehensive characterization of central and peripheral markers. We intend to achieve this aim by assessing lifestyle intervention-induced changes in functional and structural MRI brain measures, as well as peripheral measures of the gut-immune-brain axis involved in cognitive ageing. Clinical Trial: ClinicalTrials.gov ID NCT05777863 ToetsingOnline.nl filenumber NL78263.091.21


  • Open Access

    The effects of a multidomain lifestyle intervention on brain functioning and its relation with immunometabolic markers and intestinal health in older adults at-risk of cognitive ageing: study design and baseline characteristics of the HELI randomized controlled trial (Preprint)

    by Mark R. van Loenen, Lianne B. Remie, Mara P.H. van Trijp, Michelle G. Jansen, José P. Marques, Jurgen A.H.R. Claassen, Ondine van de Rest, Yannick Vermeiren, Nynke Smidt, Sietske A.M. Sikkes, et al.

    BACKGROUND Studies of multidomain lifestyle interventions show mixed results on preventing or delaying cognitive decline in ageing. A better understanding of the mechanisms underlying these interventions could help explain these mixed findings. OBJECTIVE The HELI study aims to investigate the brain and peripheral mechanisms of a multidomain lifestyle intervention in older adults at risk of cognitive decline. METHODS The HELI study is a 6-month multicentre, randomized, controlled multidomain lifestyle intervention trial powered to include 104 Dutch older adults at risk of cognitive decline. Individuals were deemed at risk when scoring ≥2 points on a lifestyle-modifiable risk factor scale (e.g. overweight, physical inactivity, hypertension, hypercholesterolemia). The multidomain lifestyle intervention consisted of five domains (diet, physical activity, stress management/mindfulness, cognitive training, and sleep) and participants were randomized in one of two intervention groups: (1) a high-intensity coaching group consisting of weekly supervised online and on-site group meetings, exercises and learning materials from lifestyle-specific course modules, and (2) a low-intensity coaching group consisting of general lifestyle-related health information sent through e-mail every two weeks. The primary study outcomes are changes between baseline and 6-month follow-up in (1) brain activation in dorsolateral prefrontal cortex (dlPFC) and hippocampus and task accuracy during an fMRI working memory task (2) ASL-quantified cerebral blood flow in dlPFC and hippocampus, (3) systemic inflammation from blood plasma (IL-6, TNF-α, hs-CRP) and (4) microbiota profile from faeces (gut microbiome diversity (Shannon and phylogenetic diversity) and richness (Chao1)). In addition, we will investigate intervention-induced gut-immune-brain links by assessing the relation between the effects found in the aforementioned primary brain and gut outcome measures. Secondary study outcomes include (1) structural and neurochemical MRI, (2) anthropometric measurements, (3) neuropsychological test battery scores, (4) lifestyle-domain related measures from questionnaire scores and a smartwatch, and an array of peripheral measures from (5) faecal analysis, (6) blood analysis, and (7) breath analysis. RESULTS Between April 2022 and October 2023 we have successfully included n = 102 older Dutch adults (mean age: 66.6 (SD: 4.3) years; 65.7% female) with ≥2 lifestyle-modifiable risk factors of cognitive ageing (median risk: 3 (IQR: 2, 3)). The most common self-reported lifestyle-modifiable risk factors of cognitive ageing at baseline were overweight or obesity (74.5%), followed by hypertension (56.9%), hypercholesterolemia (55.9%), and physical inactivity (55.9%). CONCLUSIONS The HELI study aims to enhance our understanding of working mechanisms of multidomain lifestyle interventions through its comprehensive characterization of central and peripheral markers. We intend to achieve this aim by assessing lifestyle intervention-induced changes in functional and structural MRI brain measures, as well as peripheral measures of the gut-immune-brain axis involved in cognitive ageing. CLINICALTRIAL ClinicalTrials.gov ID NCT05777863 ToetsingOnline.nl filenumber NL78263.091.21


  • Open Access

    Evaluation of inter- and intra-variability in gut health markers in healthy adults using an optimised faecal sampling and processing method

    by Kirsten Kruger, Yoou Myeonghyun, Nicky van der Wielen, Dieuwertje E. Kok, Guido J. Hooiveld, Shohreh Keshtkar, Marlies Diepeveen-De Bruin, Michiel G. J. Balvers, Mechteld Grootte-Bromhaar, Karin Mudde, et al.

    Despite advances in gut health research, the variability of important gut markers within individuals over time remains underexplored. We investigated the intra-individual variation of various faecal gut health markers using an optimised processing protocol aimed at reducing variability. Faecal samples from ten healthy adults over three consecutive days demonstrated marker-specific intra-individual coefficients of variation (CV%), namely: stool consistency (16.5%), water content (5.7%), pH (3.9%), total SCFAs (17.2%), total BCFAs (27.4%), total bacteria and fungi copies (40.6% and 66.7%), calprotectin and myeloperoxidase (63.8% and 106.5%), and untargeted metabolites (on average 40%). For thirteen microbiota genera, including Bifidobacterium and Akkermansia, variability exceeded 30%, whereas microbiota diversity was less variable (Phylogenetic Diversity 3.3%, Inverse Simpson 17.2%). Mill-homogenisation of frozen faeces significantly reduced the replicates CV% for total SCFAs (20.4–7.5%) and total BCFAs (15.9–7.8%), and untargeted metabolites compared to faecal hammering only, without altering mean concentrations. Our results show the potential need for repeated sampling to accurately represent specific gut health markers. We also demonstrated the effectiveness of optimised preprocessing of human stool samples in reducing overall analytical variability.


  • Open Access

    Detailed Analysis of Prebiotic Fructo- and Galacto-Oligosaccharides in the Human Small Intestine

    by Mara P. H. van Trijp, Melany Rios-Morales, Madelon J. Logtenberg, Shohreh Keshtkar, Lydia A. Afman, Ben Witteman, Barbara Bakker, Dirk-Jan Reijngoud, Henk Schols, Guido J. E. J. Hooiveld

    Galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) are food ingredients that improve human health, but their degradation throughout the human small intestine is not well understood. We studied the breakdown kinetics of FOS and GOS in the intestines of seven healthy Dutch adults. Subjects were equipped with a catheter in the distal ileum or proximal colon and consumed 5 g of chicory-derived FOS (degree of polymerization (DP) DP2-10), and 5 g of GOS (DP2-6). Postprandially, intestinal content was frequently collected until 350 min and analyzed for mono-, di-, and oligosaccharides. FOS and GOS had recoveries of 96 ± 25% and 76 ± 28%, respectively. FOS DP ≥ 2 and GOS DP ≥ 3 abundances in the distal small intestine or proximal colon matched the consumed doses, while GOS dimers (DP2) had lower recoveries, namely 22.8 ± 11.1% for β-D-gal-(1↔1)-α-D-glc+β-D-gal-(1↔1)-β-D-glc, 19.3 ± 19.1% for β-D-gal-(1 → 2)-D-glc+β-D-gal-(1 → 3)-D-glc, 43.7 ± 24.6% for β-D-gal-(1 → 6)-D-gal, and 68.0 ± 38.5% for β-D-gal-(1 → 4)-D-gal. Lactose was still present in the distal small intestine of all of the participants. To conclude, FOS DP ≥ 2 and GOS DP ≥ 3 were not degraded in the small intestine of healthy adults, while most prebiotic GOS DP2 was hydrolyzed in a structure-dependent manner. We provide evidence on the resistances of GOS with specific β-linkages in the human intestine, supporting the development of GOS prebiotics that resist small intestine digestion.


  • Open Access

    An optimised approach to evaluate variability in gut health markers in healthy adults

    by Kirsten Krüger, Yoou Myeonghyun, Nicky van der Wielen, Dieuwertje Kok, Guido J. Hooiveld, Shohreh Keshtkar, Marlies Diepeveen-De Bruin, Michiel G.J. Balvers, Mechteld Grootte-Bromhaar, Karin Mudde, et al.

    Despite advances in gut health research, the variability of important gut markers within individuals over time remains underexplored. We investigated the intra-individual variation of various faecal gut health markers using an optimised processing protocol aimed at reducing variability. Faecal samples from ten healthy adults over three consecutive days demonstrated marker-specific intra-individual coefficients of variation (CV%), namely: stool consistency (16.5%), water content (5.7%), pH (3.9%), total SCFAs (17.2%), total BCFAs (27.4%), total bacteria and fungi copies (40.6% and 66.7%), calprotectin and myeloperoxidase (63.8% and 106.5%), and untargeted metabolites (on average 40%). For thirteen microbiota genera, including Bifidobacterium and Akkermansia , variability exceeded 30%, whereas microbiota diversity was less variable (Phylogenetic Diversity 3.3%, Inverse Simpson 17.2%). Mill-homogenisation of frozen faeces significantly reduced the replicates CV% for total SCFAs (20.4% to 7.5%) and total BCFAs (15.9% to 7.8%), and untargeted metabolites compared to only faecal hammering, without altering mean concentrations. Our results show the potential need for repeated sampling to accurately represent specific gut health markers. We also demonstrated the effectiveness of optimised preprocessing of stool samples in reducing overall analytical variability.